top of page
Reflections on Psychiatry & Psychology


Therapeutic Alliance as a Predictor of Outcome in Treatment of Cocaine Dependence
Study of 252 cocaine-dependent patients tested whether early therapeutic alliance predicts drug-treatment outcomes across several therapies. Alliance weakly predicted outcomes (better for depression than drug use). Design issues—many variables and mixed treatments—may have limited conclusions.
Julie Myers, PsyD, MSCP
Apr 24, 20224 min read


How Decision Fatigue Can Affect Your Recovery
Decision-making uses limited mental energy (“decision fatigue”). As energy declines, resisting habitual substance use becomes harder. Recovery improves when people conserve mental energy by building routines, reducing temptations, planning ahead, and supporting decision capacity.
Julie Myers, PsyD, MSCP
Mar 27, 20223 min read


What’s Your Caffeine IQ?
Moderate caffeine (2–3 cups/day) is usually safe, but heavy use (>500 mg) can cause anxiety, insomnia, GI issues, and heart problems; withdrawal may trigger headaches and fatigue.
Julie Myers, PsyD, MSCP
Feb 20, 20221 min read


What is Biofeedback?
Biofeedback uses tech to monitor body signals like heart rate and muscle tension, helping you gain awareness and control, reducing stress, pain, anxiety, and other conditions.
Julie Myers, PsyD, MSCP
Jan 23, 20222 min read


A Terrified Man
Winston, long prone to anxiety, feared ALS after a referral. Therapy and meds eased his health anxiety and he thrived—until ALS was confirmed. He chose to focus on family, stayed positive, and kept in touch for refills until his death about 14 months later.
Alexander Papp, MD
Dec 26, 20213 min read


What's in your Genes?
Years of trial-and-error approach can be averted by this relatively new tool in mental health assessment. The psychiatrist will be able to devise an effective treatment, without side effects.
Alexander Papp, MD
Nov 28, 20212 min read


Ketamine Dreams 2: Travels through Memories of Land and People
Ketamine often brings strong relief from chronic depression—and for some, meaningful psychedelic experiences that feel uplifting and deeply personal.
Alexander Papp, MD
Oct 31, 20214 min read


Through the Stomach to the ... Brain!
Research shows a two-way gut–brain link: gut bacteria shape brain development and influence mood. Dysbiosis may contribute to anxiety and depression. Probiotics show mental health benefits, but aren’t yet FDA-regulated or reliable stand-alone treatments.
Alexander Papp, MD
Sep 26, 20213 min read


Ketamine Dreams 1: Visions of Sand and Stars in Patient Narratives
Ketamine patients describe vivid, shifting “trip” themes. One saw recurring sand cliffs and morphing faces; another experienced stars, space, and calm out-of-body states. Trips varied but often developed consistent personal motifs over time.
Alexander Papp, MD
Aug 29, 20214 min read


Taking Control of Your Cravings
If you can identify your triggers, you have taken the first step toward genuine control of your cravings.
Julie Myers, PsyD, MSCP
Jul 25, 20212 min read


Psychotherapy Coordinated with Ketamine Treatment
Carla, 48, battled anxiety and panic since 16, relying on long-term meds without therapy. Ketamine-assisted psychotherapy helped her confront childhood trauma, easing rigid thinking and accelerating recovery.
Alexander Papp, MD
Jun 27, 20213 min read


I Feel Better, Now What?
After 20 years of depression, Jack improved in 2 weeks on Paxil. But feeling better upended his “depressed” life—job, friends, marriage—causing crisis. Lesson: patients with chronic illness must prepare for change and continue therapy when they improve.
Alexander Papp, MD
May 30, 20212 min read


Pharma Company Evergreening
Pharma has saved millions but is driven by profit. New drugs are priced high to recoup R&D costs; when patents expire, generics get cheaper. Companies often use tactics to extend profits beyond patent life.
Alexander Papp, MD
Apr 25, 20213 min read


When Ketamine Is No Longer Indicated, or a Disappointed Patient
One of the advantages of Ketamine being administered in a general psychiatric practice is that it is easy to catch changes in the clinical presentation, changes that may necessitate reevaluating the feasibility of the Ketamine treatment on the spot.
Alexander Papp, MD
Mar 28, 20213 min read


When the Ketamine Trip is a Dud
Ketamine’s antidepressant effects don’t require psychedelic “trips.” Some patients feel nothing during treatment yet still show typical mood improvement afterward.
Alexander Papp, MD
Feb 28, 20213 min read


New Ways of Thinking about Suicide
Suicide is the 10th leading US death. Predicting it is hard; only clozapine, lithium, and ketamine reduce risk. Genetics, stress, and access to means all contribute.
Alexander Papp, MD
Jan 31, 20213 min read


I Quit Using. So Why Don't I Feel Happy?
After quitting drugs, many feel bored because drugs flood the brain with dopamine, dulling natural rewards. With time and practice engaging in healthy activities, the brain can relearn to find pleasure in everyday life.
Julie Myers, PsyD, MSCP
Dec 27, 20202 min read


What's in a Name, or the Curious Drug called Topiramate
Drug labels can mislead: meds are named for first uses, but act by mechanism. Topiramate (Topamax) began as seizure and migraine treatment, yet is also used off-label for mood stabilization or weight loss, among others.
Alexander Papp, MD
Nov 29, 20203 min read


Self-pay versus Insurance-based Practice
A JAMA Psychiatry study found U.S. psychiatrists increasingly go cash-only (19% to 27%). Self-pay visits are longer and more frequent, suggesting higher value than brief insurance “med checks.”
Alexander Papp, MD
Oct 25, 20202 min read


Lavender Oil for Anxiety and Sleep: The Science Behind Linalool, Silexan, and CalmAid
Lavender, used since antiquity, may ease anxiety. Its compounds (linalool, linalyl acetate) act on serotonin and NMDA receptors. Silexan (Calm-Aid) is a studied extract; consult your doctor due to potential drug interactions.
Alexander Papp, MD
Sep 27, 20202 min read
bottom of page